Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy

W P Hosch1, J Rudi, W Stremmel

  • 1Department of Gastroenterology, University of Heidelberg.

Zeitschrift Fur Gastroenterologie
|August 24, 1999
PubMed

Insights

Pseudomyxoma peritonei (PMP) is a rare condition causing mucus on the peritoneum, often from the appendix. Intraperitoneal chemotherapy with 5-FU, mitomycin C, or cisplatin is recommended for appendiceal PMP due to high recurrence rates.

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Pathology

Background:

  • Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous lesions on the peritoneal surface.
  • Typically affects middle-aged or older adults, with an incidence of approximately 2 in 10,000 laparotomies.
  • Most cases originate from the appendix or ovaries, presenting insidiously with long-term survival and minimal distant spread.

Purpose of the Study:

  • To review the literature on Pseudomyxoma peritonei (PMP) and its treatment.
  • To present ten cases of PMP of appendiceal origin.
  • To recommend effective treatment strategies for PMP, particularly intraperitoneal chemotherapy.

Main Methods:

  • Literature review on Pseudomyxoma peritonei (PMP) and its management.
  • Analysis of ten cases of PMP with appendiceal origin.
  • Evaluation of treatment efficacy, focusing on surgical resection and chemotherapy.

Main Results:

  • Surgical resection and removal of mucinous material are the primary treatments for PMP.
  • Disease recurrence is common, and adjuvant/palliative chemotherapy regimens are not well-established.
  • Intraperitoneal chemotherapy may offer superior local drug concentrations compared to systemic administration.

Conclusions:

  • Intraperitoneal chemotherapy with 5-FU, mitomycin C, or cisplatin is recommended for appendiceal PMP.
  • This approach is based on the potential for higher local drug concentrations and the experience from ten reported cases.
  • Further research into standardized chemotherapy regimens for PMP is warranted.

Related Concept Videos

Appendicitis01:19

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...